Quantification method of ethanolamine phosphate, oxidoreductase for quantification, composition for quantification, kit for quantification and sensor for quantification

Patent metadata

Field	Value
Publication number	US-11879149-B2
Application number	US-202117345187-A
Country	US
Kind code	B2
Filing date	Jun 11, 2021
Priority date	Dec 13, 2018
Publication date	Jan 23, 2024
Grant date	Jan 23, 2024

Abstract

There is provided a novel quantification method for quantifying a concentration of EAP, which is a biomarker of depression, an enzyme for quantitation, a composition for quantitation, a kit for quantitation or a sensor for quantitation. There is provided a quantification method of ethanolamine phosphate by adding oxidoreductase to a sample containing ethanolamine phosphate. A mediator may be reduced by adding the oxidoreductase, and the reduced mediator may be reacted with a reagent to determine a concentration of ethanolamine phosphate. In addition, hydrogen peroxide produced by adding the oxidase as the oxidoreductase may be reacted with a reagent to determine a concentration of the ethanolamine phosphate.

First claim

What is claimed is:

1. A quantitation method of ethanolamine phosphate comprising:
adding an oxidoreductase to a sample containing ethanolamine phosphate, and
allowing the oxidoreductase to act on the ethanolamine phosphate as a substrate,
wherein the oxidoreductase is an oxidoreductase belonging to EC NO: 1.4 or EC NO: 1.5.

2. The quantitation method of ethanolamine phosphate according to claim 1 further comprising:
reducing a mediator by adding the oxidoreductase; and
reacting the reduced mediator with a reagent to determine concentration of the ethanolamine phosphate in the sample.

3. The quantitation method of ethanolamine phosphate according to claim 1 ,
wherein
the oxidoreductase is an oxidase, and
hydrogen peroxide produced by adding the oxidase is reacted with a reagent to determine a concentration of the ethanolamine phosphate.

4. The quantitation method of ethanolamine phosphate according to claim 1 , wherein the oxidoreductase is an oxidase belonging to EC NO: 1.4.3 or EC NO: 1.5.3.

5. The quantitation method according to claim 1 , wherein the oxidoreductase is selected from the group consisting of primary amine dehydrogenase, monoamine dehydrogenase, diamine dehydrogenase, polyamine dehydrogenase, ethanolamine dehydrogenase, tyramine dehydrogenase, phenylethylamine dehydrogenase, benzylamine dehydrogenase, histamine dehydrogenase, serotonin dehydrogenase, spermine dehydrogenase, spermidine dehydrogenase, β-alanine dehydrogenase, γ-aminobutyric acid (GABA) dehydrogenase, taurine dehydrogenase, cadaverine dehydrogenase, and agmatine dehydrogenase.

6. The quantitation method according to claim 3 , wherein the oxidase is selected from the group consisting of primary amine oxidase, monoamine oxidase, diamine oxidase, polyamine oxidase, ethanolamine oxidase, tyramine oxidase, phenylethylamine oxidase, benzylamine oxidase, histamine oxidase, serotonin oxidase, spermine oxidase, spermidine oxidase, β-alanine oxidase, γ-aminobutyric acid (GABA) oxidase, taurine oxidase, cadaverine oxidase, and agmatine oxidase.

7. The quantitation method according to claim 5 , wherein the oxidoreductase is a taurine dehydrogenase that includes a large subunit.

Assignees

• Kikkoman Corp

Inventors

• Ichiyanagi Atsushi
• Masakari Yosuke
• HIRAGUCHI Haruka

Classifications

• C12Q1/52 Primary

  involving transaminase · CPC title

• C12N9/0022

  with oxygen as acceptor (1.4.3) · CPC title

• C12N9/0032

  with oxygen as acceptor (1.5.3) · CPC title

• C12Q1/26

  involving oxidoreductase · CPC title

• C12Y104/03021 Primary

  Primary-amine oxidase (1.4.3.21), i.e. VAP-1 · CPC title